• Info
  • Insider Ownership

Insider Trading & Ownership of Michael Patrick Miller

Location
Dublin 4
Summary
The estimated net worth of Michael Patrick Miller is at least $270,524 dollars as of 03 Feb 2026. Michael Patrick Miller is the Director of PUMA BIOTECHNOLOGY, INC. and owns shares of PUMA BIOTECHNOLOGY, INC. (PBYI) stock worth about $262.5K. Michael Patrick Miller is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $8K.
Signature
/s/ Raymond Furey (Attorney-in-Fact)
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Michael Patrick Miller and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Michael Patrick Miller has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $270,524.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: PUMA BIOTECHNOLOGY, INC. ($262,515).
  • Past-year value change for that position: -$97,228.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Michael Patrick Miller

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PBYI PUMA BIOTECHNOLOGY, INC. Director $262,515 -$97,228 -27% 11 Nov 2025
RIGL RIGEL PHARMACEUTICALS INC Director $8,009 01 Feb 2026
BTAI BioXcel Therapeutics, Inc. Director 09 Jan 2026

Insider Transactions Reported by Michael Patrick Miller:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.